Literature DB >> 9437623

Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers.

J L Marks1, E M Hill, C S Pomerleau, S A Mudd, F C Blow.   

Abstract

We compared nicotine dependence and withdrawal in male alcoholic and control ever-smokers, controlling for relevant demographic and clinical variables. Alcoholics were more likely to meet criteria for moderate or severe nicotine dependence and endorse more nicotine dependence symptoms. Symptoms reported more frequently by alcoholics included: (a) using nicotine in larger amounts or over a longer time than intended; (b) continued use despite problems caused or exacerbated by nicotine; (c) marked tolerance; and (d) experiencing characteristic nicotine withdrawal symptoms. Alcoholics also smoked more heavily. Other than "headaches," and "decreased heart rate," alcoholics consistently endorsed nicotine withdrawal symptoms at a higher rate. After controlling for demographic and clinical variables and level of nicotine dependence, only "feel depressed" differed significantly between groups. Our research supports previous findings suggesting that nicotine dependence is more severe in those with a history of alcohol dependence. As a result, alcoholics may experience greater discomfort from nicotine withdrawal upon smoking cessation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9437623     DOI: 10.1016/s0740-5472(97)00049-4

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  43 in total

1.  Characterizing and identifying "hard-core" smokers: implications for further reducing smoking prevalence.

Authors:  S Emery; E A Gilpin; C Ake; A J Farkas; J P Pierce
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

2.  Smoking initiation among nonsmokers during and following treatment for alcohol use disorders.

Authors:  Karen B Friend; Maria E Pagano
Journal:  J Subst Abuse Treat       Date:  2004-04

3.  Smoking cessation and alcohol consumption in individuals in treatment for alcohol use disorders.

Authors:  Karen B Friend; Maria E Pagano
Journal:  J Addict Dis       Date:  2005

Review 4.  Framing tobacco control efforts within an ethical context.

Authors:  B J Fox
Journal:  Tob Control       Date:  2005-08       Impact factor: 7.552

5.  Attitudes toward the integration of smoking cessation treatment into drug abuse clinics.

Authors:  Bret E Fuller; Joseph Guydish; Janice Tsoh; Malcolm S Reid; Michael Resnick; Lucy Zammarelli; Douglas M Ziedonis; Clare Sears; Dennis McCarty
Journal:  J Subst Abuse Treat       Date:  2006-09-26

6.  Effects of chronic alcohol dependence and chronic cigarette smoking on cerebral perfusion: a preliminary magnetic resonance study.

Authors:  Stefan Gazdzinski; Timothyc Durazzo; Geon-Ho Jahng; Frank Ezekiel; Peter Banys; Dieterj Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2006-06       Impact factor: 3.455

Review 7.  Current perspectives on smoking cessation among substance abusers.

Authors:  Maria A Sullivan; Lirio S Covey
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

8.  Nicotine withdrawal in U.S. smokers with current mood, anxiety, alcohol use, and substance use disorders.

Authors:  Andrea H Weinberger; Rani A Desai; Sherry A McKee
Journal:  Drug Alcohol Depend       Date:  2009-12-16       Impact factor: 4.492

9.  Association of smoking with μ-opioid receptor availability before and during naltrexone blockade in alcohol-dependent subjects.

Authors:  Elise M Weerts; Gary S Wand; Hiroto Kuwabara; Xiaoqiang Xu; J James Frost; Dean F Wong; Mary E McCaul
Journal:  Addict Biol       Date:  2012-12-18       Impact factor: 4.280

10.  Predictors of tobacco and alcohol co-use from ages 15 to 32: The Amsterdam Growth and Health Longitudinal Study.

Authors:  Sterling M McPherson; Ekaterina Burduli; Crystal Lederhos Smith; Olivia Brooks; Michael F Orr; Celestina Barbosa-Leiker; Trynke Hoekstra; Michael G McDonell; Sean M Murphy; Matthew Layton; John M Roll
Journal:  Exp Clin Psychopharmacol       Date:  2018-08-27       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.